Visualizing the resolution of innate immune responses during influenza infection
可视化流感感染期间先天免疫反应的解决
基本信息
- 批准号:9899365
- 负责人:
- 金额:$ 23.1万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-01-15 至 2021-12-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAntigen-Presenting CellsAntiviral AgentsApoptosisApoptoticAreaBiochemical ProcessCell CommunicationCell Differentiation processCell physiologyCellsCessation of lifeDataDependenceDetectionDevelopmentDiseaseEpithelialEpitheliumExcisionFunding OpportunitiesImmuneImmune responseImmunologicsIn SituInfectionInflammationInflammatoryInfluenzaInjuryInnate Immune ResponseKnowledgeMediatingMicroscopyModelingMolecularMorbidity - disease rateMusNatural ImmunityNeutrophil ActivationNeutrophil InfiltrationNeutrophilic InfiltrateOrgan failurePatientsPatternPeripheralPhagocytesPhaseProcessPropertyResolutionRoleSiteSystemT cell responseT-Cell ActivationT-LymphocyteTestingTissuesTracheaUnited StatesVaccinationVaccinesVirusVirus DiseasesVisualizationadaptive immune responsecell motilitycytotoxic CD8 T cellseffector T cellin vivoinfluenzavirusinnate immune mechanismslymph nodesmigrationmonocytemortalitymulti-photonneutrophilnovelnovel therapeutic interventionpandemic diseasepathogenrecruitrepairedresponseuniversal vaccine
项目摘要
Evidence from recent major epidemics suggests that both direct viral cytopathicity and inflammation-mediated tissue damage are equally important factors that potentiate the host lethality. Thus, the therapeutic strategy to bridle excessive immune damage has been proposed for severe respiratory infections. While clearance of influenza-infected cells is primarily mediated by cytotoxic CD8+ T cells, the now well-established dependency of anti-viral host responses on both innate and adaptive immune compartments suggests that harnessing the innate immunity might form a basis for the development of effective vaccines and novel therapeutic approaches. Early recruitment of leukocytes from the blood to sites of tissue infection is a hallmark of innate immune responses. However, it is currently not known how apoptotic immune cells are removed within inflamed tissues during the resolution phase – a process fundamental to our understanding and manipulation of inflammatory diseases. Despite recent advances in studies concerning phagocytic removal of apoptotic cells, the visualization of the dynamic cell clearance process in vivo has been extremely challenging. Here we propose to develop a novel intravital multi-photon microscopy (IV-MPM) system to address critical knowledge gaps regarding the function and fate of innate immune cells during the influenza infection, and their roles in anti-viral immune responses. We will (1) develop the IV-MPM system to visualize in situ neutrophil efferocytosis during resolution of influenza infection in the upper (trachea) and lower (lung) airway, and (2) develop a novel tissue-resident phagocyte fate-mapping assay to study the immunological consequence of the neutrophil efferocytosis. With these new approaches in a mouse influenza infection model, we will be able to identify novel interactions between innate and adaptive immune systems during the influenza infection. Given the importance of dynamic immune modulatory properties during viral infections, the development of novel research tools to elucidate the relationship between innate immunity and effector T cell interactions at the site of infection is critical for deciphering the basis of productive and nonproductive adaptive immune responses and for advancing our capacity to develop new universal vaccines that rely on such cell mediated responses.
最近主要发作的证据表明,直接病毒细胞病变和炎症介导的组织损伤都是潜在宿主致死性的重要因素。这是针对严重的呼吸道感染提出了过多的免疫过滤的治疗策略。虽然受影响的受影响的受影响的细胞的清除主要由细胞毒性CD8+ T细胞介导,但现在抗病毒宿主反应对先天性和适应性免疫机构的良好依赖性表明,利用先天性免疫抑制可能会构成有效疫苗和新型治疗方法的发展的基础。从血液到组织感染部位的白细胞早期招募是先天免疫调查的标志。但是,目前尚不清楚在分辨率阶段如何在发炎的组织中去除凋亡的免疫细胞,这是我们对炎症性疾病的理解和操纵基本的过程。尽管在有关吞噬细胞的吞噬细胞去除的研究中最近取得了进步,但体内动态细胞清除过程的可视化仍然极为挑战。在这里,我们建议开发一种新型的插入式多光子显微镜(IV-MPM)系统,以解决有关在影响力感染的影响期间与先天免疫细胞功能和命运的关键知识差距,以及它们在抗病毒免疫反应中的作用。我们将(1)开发IV-MPM系统,以在上部(气管)和下部(肺)气道分辨出造影症感染期间可视化原位中性粒细胞效率,以及(2)发展了一种新型的居民居民吞噬吞噬型映射评估,以研究中性粒细胞症的免疫学后果。通过小鼠影响力感染模型中的这些新方法,我们将能够在影响力感染期间识别先天和适应性免疫系统之间的新型相互作用。鉴于在病毒感染过程中动态免疫调节特性的重要性,新型研究工具的开发以阐明先天免疫学和感染部位的效应T细胞相互作用之间的关系对于破译生产性和非生产性适应性免疫响应的基础至关重要
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Minsoo Kim其他文献
Minsoo Kim的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Minsoo Kim', 18)}}的其他基金
Complement C1q and sepsis associated fatalities
补充 C1q 和脓毒症相关死亡
- 批准号:
10515703 - 财政年份:2022
- 资助金额:
$ 23.1万 - 项目类别:
Complement C1q and sepsis associated fatalities
补充 C1q 和脓毒症相关死亡
- 批准号:
10643889 - 财政年份:2022
- 资助金额:
$ 23.1万 - 项目类别:
Complement C1q and sepsis associated fatalities
补充 C1q 和脓毒症相关死亡
- 批准号:
10832821 - 财政年份:2022
- 资助金额:
$ 23.1万 - 项目类别:
Functional genomic investigation of complement signaling in the human brain
人脑补体信号传导的功能基因组研究
- 批准号:
10389218 - 财政年份:2021
- 资助金额:
$ 23.1万 - 项目类别:
Visualizing the resolution of innate immune responses during influenza infection
可视化流感感染期间先天免疫反应的解决
- 批准号:
10084273 - 财政年份:2020
- 资助金额:
$ 23.1万 - 项目类别:
Identification of a Damaging Subset of Neutrophils that Arises in Septic Patients
脓毒症患者中出现的破坏性中性粒细胞亚群的鉴定
- 批准号:
10179456 - 财政年份:2019
- 资助金额:
$ 23.1万 - 项目类别:
T cell migration and cardiovascular toxicity in immunotherapy
免疫治疗中的 T 细胞迁移和心血管毒性
- 批准号:
10646491 - 财政年份:2019
- 资助金额:
$ 23.1万 - 项目类别:
T cell migration and cardiovascular toxicity in immunotherapy
免疫治疗中的 T 细胞迁移和心血管毒性
- 批准号:
9981638 - 财政年份:2019
- 资助金额:
$ 23.1万 - 项目类别:
T cell migration and cardiovascular toxicity in immunotherapy
免疫治疗中的 T 细胞迁移和心血管毒性
- 批准号:
9814149 - 财政年份:2019
- 资助金额:
$ 23.1万 - 项目类别:
相似国自然基金
具有温度/pH双重响应和甘露糖受体靶向功能的微凝胶疫苗
- 批准号:51903233
- 批准年份:2019
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
基于DNA自组装技术的人工抗原呈递细胞设计构建及其免疫功能评价
- 批准号:21907073
- 批准年份:2019
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
高同型半胱氨酸血症放大高脂引起动脉粥样硬化早期发病--管周脂肪的抗原呈递作用
- 批准号:91439206
- 批准年份:2014
- 资助金额:270.0 万元
- 项目类别:重大研究计划
内淋巴囊上皮细胞在内耳免疫调控作用中的分子机制研究
- 批准号:81371084
- 批准年份:2013
- 资助金额:70.0 万元
- 项目类别:面上项目
基于短寿蛋白肿瘤疫苗诱导的抗瘤作用及其机制的研究
- 批准号:30771999
- 批准年份:2007
- 资助金额:33.0 万元
- 项目类别:面上项目
相似海外基金
Targeting abnormal alveolar immune activation and failed epithelial repair in COVID-19
针对 COVID-19 中异常的肺泡免疫激活和失败的上皮修复
- 批准号:
10596990 - 财政年份:2022
- 资助金额:
$ 23.1万 - 项目类别:
HSV-1 Encoded MicroRNAs in the Pathogenesis and Treatment of Ocular Herpes
HSV-1 编码的 MicroRNA 在眼疱疹发病机制和治疗中的作用
- 批准号:
10391770 - 财政年份:2022
- 资助金额:
$ 23.1万 - 项目类别:
Targeting abnormal alveolar immune activation and failed epithelial repair in COVID-19
针对 COVID-19 中异常的肺泡免疫激活和失败的上皮修复
- 批准号:
10391970 - 财政年份:2022
- 资助金额:
$ 23.1万 - 项目类别:
SELECTION OF VACCINE ANTIGENS FOR PROTECTION FROM HEPATITIS C VIRUS INFECTION
选择预防丙型肝炎病毒感染的疫苗抗原
- 批准号:
10207624 - 财政年份:2020
- 资助金额:
$ 23.1万 - 项目类别:
Visualizing the resolution of innate immune responses during influenza infection
可视化流感感染期间先天免疫反应的解决
- 批准号:
10084273 - 财政年份:2020
- 资助金额:
$ 23.1万 - 项目类别: